Masimo Corp. (NASDAQ:MASI) CEO Joe Kiani thinks Apple Watch users are better off without the blood oxygen monitoring feature now that Apple Inc. (NASDAQ:AAPL) has disabled it on its latest smartwatches due to a patent dispute.
What Happened: Apple's latest attempt to dodge an import ban on its latest Apple Watch Series 9 and Apple Watch Ultra 2 has drawn a snide remark from Kiani in an interview with Bloomberg TV.
Kiani thinks that the blood oxygen monitoring feature on the latest Apple Watches is not reliable.
See Also: Here’s How To Get Up To $349 In Apple’s iPhone 7 ‘Loop Disease’ Class Action Lawsuit Settlement
"Apple is masquerading what they are offering to consumers as a reliable, medical pulse ...